Evogene Ltd.

Regulatory Filings • Aug 10, 2014

_________ false

C003����� ��"�2PublicEVOGENE LTD9756Corporation no: 512838723Stock Exchange/Market: -12369381Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121 , ,Tel: 08-9311900 , Fax: 08-9466724E.mail address: ofer.haviv@evogene.comReported via MAGNA: 10/08/2014              Time of broadcast: 10:43 10:32:06

Company site:		www.evogene.com

Reference: 2014-02-130395

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000 The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on	Waddel &Reed reports on Schedule 13G (Amendment No. 1) which was filed with the SEC by members of Waddel & Reed, with respect to their holdings in Evogene Ltd.

W_R_13_G_A_10_8_14_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
2014-02-035194
Previous names of reporting entity:
Date of revision of form structure: 14/05/2014
- - -
Name of the Signatory: : Israeli Gaffa Inbal , Position of Signatory in the reporting corporation: Company Secretary , Name of Employer Company: .
Gad Feinstein Telephone: 08-9311900 , Facsimile: 08-9466724 , E-mail: inbalig@evogene.com 1